ABSTRACT
Introduction and Aims: Most children with functional constipation (FC) improve with conventional treatments. However, a proportion of children have poor treatment outcomes. Management of intractable FC may include botulinum toxin injections, transanal irrigation, antegrade enemas, colonic resections, and in some cases sacral nerve stimulation (SNS). SNS is surgically placed, not readily available and expensive. Posterior tibial nerve stimulation (PTNS) allows transmission of electronic impulses and retrograde stimulation to the sacral nerve plexus in a portable, simple and non-invasive fashion. Objectives: To assess the efficacy and safety of transcutaneous PTNS for the treatment of FC in children.Materials and Methods: Single-center, prospective interventional study. Children 4-14 years with Rome IV diagnosis of FC received ten daily PTNS (30 min/day) sessions. Electrodes placed over skin of ankle. Strength of stimulus was below pain threshold. Outcomes were assessed during treatment and 7 days after. Results: twenty-three subjects enrolled. Two children excluded (acute gastroenteritis, COVID-19 contact). 20 completed the study (4- 14 years), (8,4+/-3,2years, 71.4 % female). We found significant improvement in the consistency of Bowel Movements (BM) (p=0.005), Fecal Incontinence (FI) (p=0.005), Abdominal pain presence (p= <0.001) and intensity (p=0.005), and a significant for improvement in blood in stools (p=0.037). There was 86.3% improvement in abdominal pain. 96.7% reported treatment satisfaction. Only one child required rescue therapy. Conclusion: We found significant improvement in stool consistency, FI, abdominal pain and hematochezia. This suggests that transcutaneous PTNS could be a promising noninvasive treatment for FC in children. Large studies are needed.